Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

Volume: 390, Issue: 10114, Pages: 2779 - 2789
Published: Dec 23, 2017
Abstract
Summary null Background null Biomarkers of intestinal inflammation, such as faecal calprotectin and C-reactive protein, have been recommended for monitoring patients with Crohn's disease, but whether their use in treatment decisions improves outcomes is unknown. We aimed to compare endoscopic and clinical outcomes in patients with moderate to severe Crohn's disease who were managed with a tight control algorithm, using clinical symptoms and...
Paper Fields
Paper Details
Title
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
Published Date
Dec 23, 2017
Journal
Volume
390
Issue
10114
Pages
2779 - 2789
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.